Raw data is attached in the supporting information files. The original articles are accessible throughout public databases such as PubMed.

Introduction {#sec005}
============

Animal models in biomedical research are important to improve *in vivo* understanding of the physiology of living organisms as well as the pathophysiology of diseases \[[@pone.0134205.ref001]\]. Despite recent advances in computer simulation \[[@pone.0134205.ref001]--[@pone.0134205.ref003]\] and other alternative methods \[[@pone.0134205.ref004],[@pone.0134205.ref005]\], animal experiments are still necessary to test new treatment strategies in pre-clinical research \[[@pone.0134205.ref006]\].

Among the different species available, small mammals are used most frequently for laboratory research. In this systematic review 'small laboratory mammals' are defined as members of the clade glires (rodents and lagomorpha). Reasons for the frequent use of small laboratory mammals are low maintenance costs, short reproduction time and availability of transgenic models \[[@pone.0134205.ref005],[@pone.0134205.ref006]\]. Experiments conducted in rodents often require anesthesia and result in euthanasia of the animal at the end of the experiment \[[@pone.0134205.ref007]\].

Anesthesia in small animals might be challenging. Specific anesthesia-related problems are mainly caused by the size of the animal. The placement of invasive hemodynamic monitoring is often difficult and may cause severe complications. Furthermore, special and expensive equipment such as surgical instruments, microscopes or mechanical ventilators for small laboratory mammals can be necessary. Hypothermia, while not exclusive to small mammals, is a special concern in these animals and an important cause of unintended death under anesthesia \[[@pone.0134205.ref008]--[@pone.0134205.ref010]\]. High metabolic rates and difficulties monitoring of respiratory \[[@pone.0134205.ref011]\] and cardiovascular function reliably \[[@pone.0134205.ref011],[@pone.0134205.ref012]\] contribute to the complexity of the anesthetic management.

Various drugs are used in experimental research. They differ in part or total from human anesthesia practice with respect to the substances themselves, dosages administered, routes of administration and form of application \[[@pone.0134205.ref006]\]. Furthermore, the usage of analgesic drugs during and/or after surgical procedures in laboratory animals is uncommon \[[@pone.0134205.ref007],[@pone.0134205.ref013]\], but has increased over time \[[@pone.0134205.ref014]\]. This lack of comparability to human clinical practice contributes to concerns raised by the society and fellow researchers regarding bioethical aspects \[[@pone.0134205.ref015]--[@pone.0134205.ref017]\] as well as translation of experimental findings back into clinical practice.

The Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines \[[@pone.0134205.ref018]\] recommend detailed description of animal characteristics, experimental procedures including anesthesia and euthanasia, as well as general aspects, such as institutional animal care and use committee approval or sample size calculation to be included in scientific publications. In spite of the essential role of complete reporting of experimental parameters for reproducibility and translation of experimental findings into phase I clinical trials, Joffe *et al*. report, after analyzing articles published over six month in three journals from the field of critical care medicine, that the methodological quality of reporting in animal experiments in the field of critical care is poor \[[@pone.0134205.ref017]\].

Considering the limited scope of this previous work, we performed a systematic review of the top ten journals in each of the categories 'Anesthesiology', 'Respiratory System' and 'Critical Care Medicine' reporting animal experimental studies. Our aim was to evaluate the frequency and quality of reporting of anesthesia, euthanasia, including animal characteristics, postoperative pain therapy, monitoring, mechanical ventilation, animal care approval, sample size calculation and performed interventions in experimental studies with small laboratory mammals, over a one year period on a broad data base. Additionally to rodents, we included lagomorpha as they are widely used in experimental research. They are also closely related to rodents and investigators face similar challenges when handling and taking care of the animals.

We hypothesized that 1) the frequency of reporting experiments involving small laboratory mammals published in the top ten journals in the categories 'Anesthesiology', 'Respiratory System' and 'Critical Care Medicine' over a one year period is high while 2) the quality of reporting in these studies is poor regarding the provision of data on anesthesia and euthanasia.

Material and Methods {#sec006}
====================

This systematic review is reported according to the PRISMA guidelines \[[@pone.0134205.ref019]\] whenever possible with the exception of: 1) the protocol registration (item 5), 2) the 'risk of bias' assessment (item 12, 19 and 22) and summary measures (risk ratio, difference in means, item 13) which were not applicable for this review.

Identification of relevant studies {#sec007}
----------------------------------

The tables of contents of the ten highest-ranked journals in each of the ISI Web of Knowledge Subject Categories 'Anesthesiology', 'Critical Care Medicine' and 'Respiratory System' were systematically searched for relevant articles. Ranks were determined based on the impact factor of the respective journal as published in the 2012 Journal Citation Reports Science Edition, accessed via ISI Web of Knowledge \[[@pone.0134205.ref020]\]. Articles published between 1^st^ January 2012 and 31^st^ December 2012 were considered for evaluation without language restriction. If a journal had been listed in more than one of the categories, the following ranked journal according to the impact factor was substituted for it in one of the respective categories. Detailed information regarding selected journals is provided in [Table 1](#pone.0134205.t001){ref-type="table"} and [S1 File](#pone.0134205.s001){ref-type="supplementary-material"}.

10.1371/journal.pone.0134205.t001

###### Identified Articles.

![](pone.0134205.t001){#pone.0134205.t001g}

  Category                                                                  Journal Title                                                Impact Factor   Included Articles   ANE              EUTH                                         ESM                                                         MethodSection                                                     Animial Care Approval[\#](#t001fn003){ref-type="table-fn"}
  ------------------------------------------------------------------------- ------------------------------------------------------------ --------------- ------------------- ---------------- -------------------------------------------- ----------------------------------------------------------- ----------------------------------------------------------------- ------------------------------------------------------------
  **Anesthesiology**                                                        Pain                                                         5.644           63 (25.6)           52 (81.3)        63 (100.0)                                   accepted                                                    no word limit                                                     statement required
  Anesthesiology                                                            5.163                                                        70 (28.5)       60 (85.7)           65 (92.9)        accepted                                     no word limit                                               statement required                                                
  British Journal of Anaesthesia                                            4.237                                                        22 (8.9)        18 (81.8)           20 (90.9)        accepted                                     no word limit, ARRIVE guidelines referenced                 statement required                                                
  Anaesthesia                                                               3.486                                                        3 (1.2)         3 (100.0)           2 (66.6)         accepted                                     no word limit, compliance with ARRIVE guidelines demanded   approval required[§](#t001fn004){ref-type="table-fn"}             
  Regional Anesthesia and Pain Medicine                                     3.464                                                        11 (4.5)        10 (90.9)           9 (81.8)         accepted                                     no word limit                                               statement required                                                
  Anesthesia and Analgesia                                                  3.300                                                        43 (17.5)       36 (83.7)           37 (86.0)        accepted                                     no word limit                                               statement required                                                
  European Journal of Pain                                                  3.067                                                        30 (12.2)       30 (100)            22 (73.3)        accepted                                     no word limit                                               statement required                                                
  Minerva Anestesiologica                                                   2.818                                                        0 (0.0)         0 (0.0)             0 (0.0)          not mentioned in authors' guidelines         no word limit                                               statement required                                                
  European Journal of Anaesthesiology                                       2.792                                                        4 (1.6)         4 (100)             3 (75.0)         accepted                                     no word limit, ARRIVE guidelines referenced                 statement required                                                
  Pain Practice                                                             2.605                                                        0 (0.0)         0 (0.0)             0 (0.0)          not mentioned in authors' guidelines         only reviews                                                statement required                                                
                                                                            **Total**                                                                    246 (29.1)          213 (86.2)       222 (89.9)                                                                                                                                                                 
  **Critical Care Medicine**                                                American Journal of Respiratory and Critical Care Medicine   11.041          32 (11.8)           16 (50)          32 (100)                                     accepted                                                    methods limited to 500 words                                      approval required
  Critical Care Medicine                                                    6.124                                                        57 (21,0)       48 (84.2)           57 (100.0)       accepted                                     no word limit                                               statement required                                                
  Chest                                                                     5.854                                                        4 (1.5)         2 (50.0)            3 (75.0)         accepted, but authors are charged 150 USD;   no word limit                                               approval[§](#t001fn004){ref-type="table-fn"}                      
  Intensive Care Medicine                                                   5.258                                                        16 (5.8)        14 (93.3)           15 (100)         accepted                                     no word limit                                               statement required                                                
  Critical Care                                                             4.718                                                        15 (5.5)        13 (81.3)           16 (100.0)       accepted                                     no word limit                                               not explicitly required                                           
  Journal of Neurotrauma                                                    4.295                                                        131 (48.1)      118 (90.0)          118 (90.0)       not mentioned in authors' guidelines         no word limit                                               statement required                                                
  Resuscitation                                                             4.104                                                        18 (6.6)        16 (88.8)           17 (94.4)        accepted                                     no word limit,appended ARRIVE checklist demanded            Review Board approval identifier required                         
  Neurocritical Care                                                        3.038                                                        0 (0.0)         0 (0.0)             0 (0.0)          not mentioned in authors' guidelines         no word limit                                               not explicitly required                                           
  Current Opinion in Critical Care                                          2.967                                                        0 (0.0)         0 (0.0)             0 (0.0)          accepted                                     only review articles                                        not applicable                                                    
  Seminars in Respiratory and Critical Care Medicine                        2.752                                                        0 (0.0)         0 (0.0)             0 (0.0)          not mentioned in authors' guidelines         only review articles                                        not applicable                                                    
                                                                            **Total** [\*](#t001fn002){ref-type="table-fn"}                              273 (32.3)          227 (83.5)       258 (94.9)                                                                                                                                                                 
  **Respiratory System**                                                    Thorax                                                       8.376           11 (3.4)            6 (54.5)         11 (100)                                     accepted                                                    no word limit                                                     not explicitly required
  European Respiratory Journal                                              5.854                                                        16 (4.9)        10 (62.5)           16 (100)         accepted;                                    no word limit                                               not explicitly required                                           
  Journal of Heart and Lung Transplantation                                 5.112                                                        14 (4.3)        9 (64.3)            14 (100.0)       not mentioned in authors' guidelines         no word limit                                               statement confirming adherence to Helsinki declaration required   
  Journal of Thoracic Oncology                                              4.473                                                        4 (1.2)         0 (0.0)             4 (100.0)        accepted                                     no word limit                                               not explicitly required                                           
  American Journal of Respiratory Cell and Molecular Biology                4.148                                                        113 (34.6)      44 (39.3)           113 (100)        accepted                                     limited to 500 words                                        not explicitly required                                           
  Respiratory Research                                                      3.642                                                        27 (8.3)        15 (55.5)           27 (100.0)       accepted                                     no word limit                                               not explicitly required                                           
  Journal of Thoracic and Cardiovascular Surgery                            3.526                                                        9 (2.8)         5 (55.5)            9 (100)          accepted                                     no word limit                                               statement required                                                
  American Journal of Physiology---Lung Cellular and Molecular Physiology   3.523                                                        115 (35.3)      58 (50.4)           115 (100.0)      accepted                                     no word limit, ARRIVE guidelines referenced                 statement required                                                
  Annals of Thoracic Surgery                                                3.454                                                        7 (2.1)         2 (28.6)            7 (100)          not mentioned in authors' guidelines         no word limit                                               statement required                                                
  Lung Cancer                                                               3.392                                                        10 (3.1)        2 (20.0)            10 (100)         accepted                                     no word limit                                               statement required                                                
                                                                            **Total** [\*](#t001fn002){ref-type="table-fn"}                              326 (38.6)          151 (46.3)       326 (100.0)                                                                                                                                                                
                                                                            **Overall**                                                                  **845 (100.0)**     **591 (69.9)**   **806 (95.4)**                                                                                                                                                             

Summary on the number of articles and journal characteristics according to the instructions to authors included in the final analysis with respect to 2012 ISI Web of Knowledge subject category, journal and impact factor. The journals \"Seminars of Respiratory and Critical Care\", \"Thorax\" and "Journal of Heart and Lung Transplant\" were substituted for \"Minerva Anestesiologica\", \"American Journal of Respiratory and Critical Care Medicine\" and \"Chest\" respectively, which were listed in more than one subject category. The substitution resulted in the inclusion of \"Annals of Thoracic Surgery\" and \"Lung Cancer\" in the present review. Values are given as number (% per category).

\*: percentage related to total number of articles (845);

^\#^: animal care approval statement in methods section according to the instructions to authors,

^§^: animal care approval required, but no explicit statement regarding animals care approval in methods section in the instructions to authors listed.

ANE: number of manuscripts involving animal anesthesia (percentages given related to number of included articles); EUTH: number of manuscripts involving animal euthanasia (percentages given related to number of included articles); ESM: Availability of an electronic online supplement.

Eligibility criteria {#sec008}
--------------------

Inclusion criteria with respect to the PICOS criteria \[[@pone.0134205.ref021]\] were as follows: 1) population: small laboratory mammals are defined as members of the clade glires (rodents and lagomorpha), also including animals used for cell and tissue isolation, 2) intervention: any form of anesthesia and / or euthanasia, 3) comparison: not specified, 4) outcome: defined by primary and secondary endpoints, 5) study: experimental studies presented in original research articles. Primary endpoints were defined as follows: 1) type of anesthesia and anesthetic agents (dosage, route of administration, form of application), 2) type of euthanasia (methods, anesthetic agents \[dosage, route of administration, form of application\]). Secondary endpoints of this review included animal characteristics, monitoring, mechanical ventilation, fluid management, postoperative pain therapy, animal care approval, sample size calculation and performed interventions.

Manuscripts were excluded, if only purchased cells were used in the reported experiments or the publication was not an original research article.

Manuscript selection and data abstraction {#sec009}
-----------------------------------------

The articles included in this review were selected by examining titles, abstracts and the full text if a potentially relevant manuscript was identified. Two authors (CU, HK) abstracted the data on the a priori defined inclusion criteria with respect to anesthesia, euthanasia and monitoring procedures as well as animal and manuscript characteristics independently and in duplicate. A posteriori, the reporting of animal characteristics, anesthesia, euthanasia and monitoring was characterized for the three categories 'Anesthesiology', 'Critical Care Medicine' and 'Respiratory System', impact factor (higher and lower as five) as well as for journals advising authors to describe anesthesia in their manuscript instructions separately. Quality of reporting was assessed as completeness of data on animal characteristics, anesthesia, euthanasia, ethical statements as well as details of the study planning as described in the ARRIVE guidelines \[[@pone.0134205.ref018]\]. Frequency of reporting describes how often a specific intervention or characteristic was stated in the analyzed data. Research protocols using several different anesthesia and/or euthanasia methods within one manuscript were counted separately. An outcome was classified as \'not specified\' if a range for the respective value or a general term (e.g. \'euthanized\', \'sacrificed\' or \'anesthetized\') was used without further description. Initial survival was defined as 'recovering from anesthesia after an intervention'. Overall survival was classified as 'no reported euthanasia and no results or procedures reported which are contradictory to life', such as histology or other tissue processing results of vital organs. A painful intervention was defined as a procedure involving organ injury, surgery or tissue stimulation. Premedication was classified as 'the administration of a drug for sedation with or without combination with analgesic agents before the induction of anesthesia'. Drugs for anesthesia maintenance were used during the experimental interventions with or without premedication. The term 'form of application' of an agent was defined as 'bolus' if a single or repetitive injection was performed or as 'continuous' which represents a constant or varying infusion rate. The purpose of monitoring is reported in four categories: experimental procedure, anesthesia only, both or not specified. Article supplements were searched whenever available.

Data synthesis {#sec010}
--------------

All analyses were performed using IBM SPSS Statistics (Vers. 20, IBM Deutschland GmbH, Ehningen, Germany). Values are given as total number and percentage of total unless specified otherwise. Animal characteristics were analyzed per publication. Anesthesia, euthanasia, as well as monitoring and mechanical ventilation were analyzed per performed intervention in each article. Percentages of outcomes were calculated with respect to the reported outcome (excluding \'not reported\' and \'not specified\'). Frequency of reporting among the journal categories and between journals with impact factor equal or greater than five and lower than five were analyzed with a chi-square or Fisher\'s exact test, if appropriate. Statistical significance was accepted at p\<0.05.

Results {#sec011}
=======

Trial identification and characteristics {#sec012}
----------------------------------------

The search yielded 5,335 experimental studies in total including 865 manuscripts describing experimental studies in small laboratory mammals. Seven of these 865 manuscripts screened in full text were excluded because neither small laboratory mammals nor cells were. Four more articles were excluded because cells were not primarily isolated, but commercially purchased. Nine papers involving rodents did not report anesthesia or euthanasia. Those nine manuscripts were excluded, too. Finally, 845 articles were included in this review. Terminal experiments were conducted in 806 (95.4%) articles. 1,041 different interventions involving anesthesia and/or euthanasia of small animals were performed. Initial survival of the intervention was reported in 455/1,041 (43.7%) of the performed interventions ([Table 2](#pone.0134205.t002){ref-type="table"}). Anesthesia was reported in 599/845 (70.8%) of manuscripts and performed in 732/1,041 (70.3%) of the interventions. Euthanasia was applied in 970/1,041 (93.1%) of the interventions including interventions with initial survival. The flowchart of the selection process is depicted in [Fig 1](#pone.0134205.g001){ref-type="fig"}.

10.1371/journal.pone.0134205.t002

###### Interventions and survival.

![](pone.0134205.t002){#pone.0134205.t002g}

  Intervention                             Species      Initial Survival   Overall Survival   Number of                                                       
  ---------------------------------------- ------------ ------------------ ------------------ ----------- ------------ ------------ ----------- ------------- --------------
  **Cell/organ harvest**                   111 (53.4)   83 (40.4)          7 (3.4)            6 (2.9)     19 (9.2)     188 (90.8)   0 (0.0)     207 (100.0)   207 (19.9)
  **Mechanical ventilation**               23 (46.0)    21 (42.0)          0 (0.0)            6 (12.0)    3 (6.0)      47 (94.0)    0 (0.0)     50 (100.0)    50 (4.8.)
  **Organ injury/surgical procedure/TS**   255 (41.5)   343 (56.4)         0 (0.0)            12 (2.1)    364 (59.7)   246 (40.3)   50 (9.2)    560 (91.8)    610 (58.6)
  **Drug administration**                  25 (27.7)    63 (67.0)          2 (2.1)            3 (3.2)     39 (41.9)    54 (58.1)    16 (17.2)   77 (82.8)     93 (8.9)
  **Measurement**                          41 (50.0)    37 (46.3)          1 (1.2)            2 (2.4)     30 (37.0)    51 (63.0)    4 (4.9)     77 (95.1)     81 (7.8)
  **Total**                                455 (43.7)   547 (52.5)         10 (1.0)           29 (2.8)    455 (43.7)   586 (56.3)   70 (6.7)    971 (93.3)    1041 (100.0)

Values are given as number (%). Initial survival was defined as 'recovering from anesthesia after an intervention'. Overall survival was defined as no reported euthanasia.

\*: the number of interventions represent the denominator to all fractions; TS: tissue stimulation.

![Flowchart.\
Studies enrolled for this systematic review. \*: small laboratory animals (clade glires).](pone.0134205.g001){#pone.0134205.g001}

Quality of reporting {#sec013}
--------------------

Of the 845 analyzed papers, 129/845 (15.3%) did not include the ethical statement on animal care approval from their institution (Table A in [S2 File](#pone.0134205.s002){ref-type="supplementary-material"}) and 837/845 (99.1%) did not include sample size calculations, both recommended in the ARRIVE guidelines \[[@pone.0134205.ref018]\]. None of the 845 analyzed papers reported on all items of the ARRIVE guidelines \[[@pone.0134205.ref018]\].

Frequency of reporting {#sec014}
----------------------

### Animal characteristics {#sec015}

Animal characteristics are described in Table B in [S2 File](#pone.0134205.s002){ref-type="supplementary-material"} and [Fig 2](#pone.0134205.g002){ref-type="fig"}. Animal species and breeding strains are summarized in [Table 3](#pone.0134205.t003){ref-type="table"}. Frequency of reporting, with respect to journal category and impact factor, is shown in [Table 4](#pone.0134205.t004){ref-type="table"}. The total number of small laboratory mammals used was not reported in 533/897 (59.4%) and not specified in 15/897 (1.7%) data sets out of 845 analyzed manuscripts. The difference between data sets and analyzed manuscripts results from the possible use of multiple species in a single manuscript. A total number of 23,009 small laboratory mammals, including 6,570/23,009 (28.5%) mice, 15,729/23,009 (68.4%) rats, 40/23,009 (0.2%) guinea pigs and 670/23,009 (2.9%) rabbits was described in the remaining 349/897 (38.9%) interventions involving different small laboratory species.

![Frequencies of reported species.\
Values are given as number; percentage relative to total (below pie diagram). Analysis was performed per publication. The total number of 897 is explained by use of multiple species among manuscripts.](pone.0134205.g002){#pone.0134205.g002}

10.1371/journal.pone.0134205.t003

###### Animal species and breeding strains.
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  Species                                      Mouse         No. (%)                                      Rat              No. (%)      Guinea pig   No. (%)          Rabbit              No. (%)
  -------------------------------------------- ------------- -------------------------------------------- ---------------- ------------ ------------ ---------------- ------------------- -----------
  **Breeding strains**                         C57BL/6       260 (59.5)                                   Spargue Dawley   297 (66.4)   Hartley      4 (44.4)         New Zealand White   23 (85.2)
  BALB/c                                       58 (13.3)     Wistar                                       98 (21.9)                                  Japanese White   2 (7.4)             
  129Sv                                        11 (2.5)      Long Evans                                   11 (2.5)                                                                        
  Swiss                                        6 (1.4)       Lewis                                        10 (2.2)                                                                        
  C3H/HeN                                      5 (1.1)       Brown Norway                                 5 (1.1)                                                                         
  Swiss Webster                                4 (0.9)       Fisher 344                                   3 (0.7)                                                                         
  other[\*](#t003fn002){ref-type="table-fn"}   41 (9.4)      other[\*](#t003fn002){ref-type="table-fn"}   15 (3.4)                                                                        
  n/r                                          52 (11.9)     n/r                                          8 (1.8)          n/r          5 (55.6)     n/r              2 (7.4)             
  total                                        437 (100.0)   total                                        447 (100.0)      total        9 (100.0)    total            27 (100.0)          

Values are given as absolute number and percentage No.(%). The total number of species and breeding strains is varying from 897, since animals were counted per strain separately. n/r: not reported;

\*: race frequency \< 0.5%.

10.1371/journal.pone.0134205.t004

###### Frequency of reporting with respect to journal categories and impact factor.
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                                                                   Category          Impact Factor                                                                        
  ---------------------------------------------------------------- ----------------- ----------------- ----------------- ------------ ----------------- ----------------- -----------
  **Animal characteristics**                                                                                                                                              
  No reported number of animals                                    115/533 (21.6%)   119/533 (22.3%)   299/533 (56.1%)   P\<0.001     376/533 (70.5%)   157/533 (29.4%)   P\<0.001
  No reported beeding strains                                      16/67 (23.8%)     15/67 (22.4%)     36/67 (53.7%)     P = 0.017    46/67 (68.7%)     21/67 (31.3%)     P = 0.511
  No reported sex                                                  37/246 (15.0%)    58/246 (23.6%)    151/246 (61.4%)   P\<0.001     183/246 (74.0%)   64/246 (26.0%)    P\<0.001
  No reported age                                                  128/391 (32.7%)   123/391 (31.5%)   140/391 (35.8%)   P = 0.086    269/391 (68.8%)   122/391 (31.2%)   P = 0.023
  No reported weight                                               67/436 (15.4%)    97/436 (22.2%)    272/436 (62.4%)   P\<0.001     312/436 (71.6%)   124/436 (28.4%)   P\<0.001
  **Anesthesia**                                                                                                                                                          
  Reported anesthesia[\*](#t004fn002){ref-type="table-fn"}         285/690 (41.3%)   257/690 (37.2%)   148/690 (21.5%)   P\<0.001     423/690 (61.3%)   267/690 (38.7%)   P\<0.001
  No reported anesthesia[^§^](#t004fn003){ref-type="table-fn"}     54/351 (15.4%)    64/351 (18.2%)    233/351 (66.4%)   P\<0.001     114/351 (32.5%)   237/351 (67.5%)   P\<0.001
  Premedication                                                    76/169 (45.0%)    71/169 (42.0%)    22/169 (13.0%)    P = 0.009    101/169 (59.8%)   68/169 (48.2%)    P = 0.636
  Analgesics for premedication                                     3/32 (9.4%)       14/32 (43.7%)     15/32 (46.9%)     P\<0.001     15/32 (46.9%)     17/32 (53.1%)     P = 0.006
  Analgesics during anesthesia                                     54/185 (29.2%)    71/185 (38.4%)    60/185 (32.4%)    P\<0.001     118/185 (63.8%)   67/185 (36.2%)    P = 0.418
  Post-interventional analgesia                                    7/38 (18.4%)      27/38 (71.1%)     4/38 (10.5%)      P\<0.001     9/38 (23.7%)      29/38 (76.3%)     P\<0.001
  Neuromuscular blocking agents                                    7/38 (18.4%)      18/38 (47.4%)     13/38 (34.2%)     P = 0.010    16/38 (42.1%)     22/38 (57.9%)     P = 0.016
  Fluid therapy                                                    22/66 (33.3%)     37/66 (56.1%)     7/66 (10.6%)      P = 0.002    41/66 (62.1%)     25/66 (37.9%)     P = 1.000
  **Euthanasia**                                                                                                                                                          
  Reported euthanasia[\*](#t004fn002){ref-type="table-fn"}         177/481 (36.8%)   183/481 (38.0%)   121/481 (25.2%)   P\<0.001     324/481 (67.4%)   157/481 (32.6%)   P = 0.039
  No reported euthanasia in interventions without survival         93/450 (20.7%)    112/450 (24.9%)   245/450 (54.4%)   P\<0.001     274/450 (68.9%)   176/450 (39.1%)   P = 0.039
  Anesthesia for euthanasia[\#](#t004fn004){ref-type="table-fn"}   124/348 (35.6%)   136/348 (39.1%)   88/348 (25.3%)    P = 0.828    245/348 (70.4%)   103/348 (25.6%)   P = 0.023
  Transcardial perfusion                                           9/37 (24.3%)      18/37 (48.7%)     10/37 (27.0%)     P = 0.231    12/37 (32.4%)     25/37 (67.6%)     P\<0.001
  Carbon dioxide                                                   11/26 (42.3%)     7/26 (26.9%)      8/26 (30.8%)      P = 0.481    16/26 (61.5%)     10/26 (38.5%)     P = 0.524
  Decapitation                                                     14/22 (63.6%)     5/22 (22.7%)      3/22 (13.6%)      P = 0.028    13/22 (59.1%)     9/22 (40.9%)      P = 0.485
  Exsanguination                                                   6/23 (26.1%)      10/23 (43.5%)     7/23 (30.4%)      P = 0.547    11/23 (47.8%)     12/23 (52.2%)     P = 0.065
  Other methods                                                    13/25 (52.0%)     7/25 (28.0%)      5/25 (20.0%)      P = 0.268    14/25 (56.0%)     11/25 (44.0%)     P = 0.272
  **Monitoring**                                                                                                                                                          
  No reported monitoring                                           96/439 (21.9%)    156/439 (35.5%)   187/439 (42.6%)   P\<0.001     248/439 (56.5%)   191/439 (43.5%)   P = 0.130
  Total reported monitoring                                        100/293 (34.1%)   137/293 (46.8%)   56/293 (19.1%)    P\<0.001     182/293 (62.1%)   111/293 (37.9%)   P = 0.130
  Heart rate (ECG or pulse plethysmography)                        13/40 (32.5%)     19/40 (47.5%)     8/40 (20.0%)      P = 0.1894   26/40 (65.0%)     14/40 (35%)       P = 0.509
  Blood pressure (invasive or non-invasive)                        53/129 (41.1%)    57/129 (44.2%)    19/129 (14.7%)    P\<0.001     57/129 (44.2%)    72/129 (55.8%)    P\<0.001
  Oxygenation (pulse plethysmography or BGA)                       33/100 (33.0%)    49/100 (49.0%)    18/100 (18.0%)    P = 0.002    46/100 (46.0%)    54/100 (54.0%)    P = 0.005
  Temperature                                                      77/198 (38.9%)    100/198 (50.5%)   21/198 (10.6%)    P\<0.001     79/198 (39.9%)    119/198 (60.1%)   P\<0.001

Values are given as number in relation to total and the respective percentage. Statistical analysis was performed using a chi-square or Fisher\'s exact test, if appropriate. Statistical significance was accepted at α = 0.05.

\*: Numbers without \'not specified\' interventions,

^§^: Numbers with included \'not specified\' interventions,

^\#^: anesthesia for euthanasia includes combination with other methods, ANE: Anesthesiology, CCM: Critical Care Medicine, RS: Respiratory System, ECG: electrocardiography, BGA: blood gas analysis

### Anesthesia {#sec016}

Detailed information regarding anesthesia is summarized in [Table 4](#pone.0134205.t004){ref-type="table"}, Table C in [S2 File](#pone.0134205.s002){ref-type="supplementary-material"} and [Fig 3](#pone.0134205.g003){ref-type="fig"}. [Table 5](#pone.0134205.t005){ref-type="table"} shows the dosages of the most commonly used anesthetics. Premedication was used in 169/732 (23.1%) of all interventions involving anesthesia. The use of analgesics, in addition to sedatives, for premedication was described in 32/169 premedications (18.9%). Anesthesia was not specified in 42/732 (5.7% interventions involving anesthesia). In detail, 185/690 interventions (26.8% of procedures specifying anesthesia) reported the use of analgesics in addition to sedatives for anesthesia in 117/690 (16.9% with respect to interventions involving anesthesia, and 117/610 (19.1%) with respect to painful interventions) surgical or organ injury procedures and 68/690 (9.9%) non-injurious interventions. In 12/185 (6.4%) of these remaining interventions, animals received post-operative pain therapy after procedures associated with surgery or organ injury. Regardless of intra-operative management, post-operative pain therapy was reported in 38/364 (10.4%) interventions in which animals underwent surgical procedures or organ injury with initial survival. The use of neuromuscular blocking agents was reported in 38/732 (5.2%) of the papers that described anesthetic procedures. Fluid therapy was described in 70/732 (9.6%) interventions involving anesthesia, using saline (44/70, 62.9%), lactated ringer solution (20/70, 28.6%), hydroxylethylstarch 6% (1/70, 1.4%) or dextrose 5% (1/70, 1.4%). In 4/70 interventions (5.7%), drugs for fluid therapy were not specified.

![Frequencies of anesthetic drugs.\
Values are given as numbers and percentages relative to the total number (below pie diagram). A: Sedative drugs for premedication. Inhalational anesthetics include: isoflurane 56 (33%) and sevoflurane 13 (8%). B: Sedative agents for anesthesia maintenance. Inhalational anesthetics include: isoflurane 225 (31%), isoflurane/nitrous oxide 36 (5%), sevoflurane 28 (4%) and halothane 20 (3%). C: Analgesic drugs for premedication. D: Analgesic drugs for anesthesia maintenance. E: Neuromuscular blocking agents. F: Analgesics for postoperative pain therapy. Other: drugs with \<1% occurrence. n/s: not specified.](pone.0134205.g003){#pone.0134205.g003}

10.1371/journal.pone.0134205.t005

###### Dosages of anesthetic drugs.

![](pone.0134205.t005){#pone.0134205.t005g}

                                                        Premedication      Anesthesia Maintenance                                                                                                                                     
  ---------------- --------------------- -------------- ------------------ -------------------------------------------------- --------- ----------- -------------------- ------------------------------------------------- ---------- ---------------
  **Sedatives**    Isoflurane            \[Vol%\]       3.9±0.9            3.9±1.0                                            n/a       n/a         2.4±1.2              2.3±1.0                                           n/a        1.75±0
                   Pentobarbital         \[mg/kg BW\]   53.3±20.8          52.1±11.0                                          n/a       n/a         70±44                44.6±14.9 \[22.6±19.7\]                           n/a        \[25.0±3.5\]
                   Xylazine              \[mg/kg BW\]   10.8±5.2           9±1                                                7.3±6.7   (4.5±4.5)   8.9±4.2              11.0±9.0 \[20.0±14.1\]                            n/a        \[3.25±2.1\]
                   Sevoflurane           \[Vol%\]       4±0                5.5±2.1                                            n/a       n/a         2.6±0.6              2.8±1.0                                           n/a        6.0±0.0
                   Isoflurane/N~2~O      \[Vol%\]       n/a                n/a                                                n/a       n/a         1.8±0.9/ 56.6±21.7   2.3±0.8/55.8±15.7                                 n/a        n/a
                   Halothane             \[Vol%\]       n/a                n/a                                                n/a       n/a         1.8±0.3              2.4±0.9                                           n/a        1.5±0.0
                   Chloral hydrate       \[mg/kg BW\]   n/a                n/a                                                n/a       n/a         460.0±56.6           251.5±143.4                                       n/a        n/a
                   Urethane              \[mg/kg BW\]   n/a                n/a                                                n/a       n/a         n/a                  1300±230                                          1500±0.0   n/a
                   Tribromo-ethanol      \[mg/kg BW\]   n/a                n/a                                                n/a       n/a         324.4±192.5          250±0                                             n/a        n/a
                   Metedomidine          \[mg/kg BW\]   n/a                n/a                                                n/a       n/a         1.0±0.0              0.58±0.23                                         n/a        (0.25±0)
  **Analgesics**   Ketamine              \[mg/kg BW\]   83.6±24.6 (60±0)   71.4±27.3 (85.0±21.2)                              n/a       21.8±13.7   95.0±41.3            74.8±23.0\[31.3±16.5\] (50.0±17.6)                n/a        \[35.0±14.4\]
                   Buprenorphine         \[mg/kg BW\]   n/a                0.025±0.007[\*](#t005fn002){ref-type="table-fn"}   n/a       n/a         n/a                  0.045±0.01[\*](#t005fn002){ref-type="table-fn"}   n/a        n/a
                   Fentanyl              \[mg/kg BW\]   n/a                n/a                                                n/a       n/a         n/a                  n/a                                               n/a        n/a
                   Remifentanil          \[mg/kg BW\]   n/a                n/a                                                n/a       n/a         n/a                  \[42.0±78.4\]                                     n/a        n/a
                   Bupivacaine           \[mg/kg BW\]   n/a                n/a                                                n/a       n/a         n/a                  n/a                                               n/a        n/a
                   Fentanyl/Fluanisone   \[mg/kg BW\]   n/a                n/a                                                n/a       n/a         n/a                  n/a                                               n/a        n/a
                   Morphine              \[mg/kg BW\]   n/a                n/a                                                n/a       n/a         n/a                  1.8±1.0[\*](#t005fn002){ref-type="table-fn"}      n/a        n/a
                   Ketoprofen            \[mg/kg BW\]   n/a                5±0                                                n/a       n/a         n/a                  n/a                                               n/a        n/a

Values are given as mean ± standard deviation and as intraperitoneal, (intramuscular) and \[intravenous (mg/kg/h)\] dosage. Anesthetic agents are ordered by frequency of utilization.

\*: subcutaneous administration, Gp: Guinea pig.

Among journals advising or referring to advising guidelines in their instructions to authors (British Journal of Anaesthesia, Anesthesiology, Journals of the American Thoracic Society and the American Journal of Physiology---Lung Cellular and Molecular Physiology) *vs*. journals without this advise, the total number and percentage of reported anesthetic methods were as follows: reporting of anesthesia (without \'not specified\'): 233/690 (33.8%) vs. 457/690 (66.2%), premedication: 42/169 (24.9%) vs. 127/169 (75.1%), analgesics for premedication: 10/32 (31.2%) vs. 22/32 (68.8%), analgesic agents during anesthesia: 73/185 (39.5%) vs. 112/185 (60.5%), post-interventional analgesia: 5/38 (12.2%) vs. 33/38 (86.8%), neuromuscular blocking agents during anesthesia: 15/38 (39.5%) vs. 23/38 (60.5%), fluid therapy: 21/66 (31.8%) vs. 45/66 (68.2%).

### Side effects of anesthesia and unexpected death {#sec017}

Side effects of anesthesia such as hypothermia, hypotension, anaphylaxis or unexpected death caused by anesthetics were not reported in the retrieved manuscripts. Unexpected death was described in eight publications (0.9% of all 845 analyzed publications). Reasons for unexpected death were experimental procedure in 6/845 (0.7%) and not further specified in 2/845 manuscripts (0.2%).

### Euthanasia {#sec018}

Type and drugs used for euthanasia are shown in [Fig 4](#pone.0134205.g004){ref-type="fig"}. Frequency of reporting, with respect to journal category and impact factor, is shown in [Table 4](#pone.0134205.t004){ref-type="table"}. Of 971 interventions (93.2% of all interventions) without survival, euthanasia was not reported in 450/971 (46.3%) and not specified in 20/971 (2.1%), respectively. Anesthetic agents were used alone in 121/501 (24.2%) of interventions with reported euthanasia method or in combination with other euthanasia methods in 227/501 (45.3%) of interventions with reported euthanasia method. Dosage of anesthetic agents was not reported in 153/348 (43.9%) and not specified in 68/348 (19.5%) of these interventions involving euthanasia, respectively. The dosages of the three most frequently used drugs were reported as follows (values given as mean ± standard deviation): 1) pentobarbital: 135.3±115.6 mg/kg (mice, intraperitoneal), 102.6±53.8 mg/kg (rats, intraperitoneal), 150.0±40.8 mg/kg (guinea pigs, intraperitoneal), 175.0±106.1 mg/kg (rabbits, intravenous); 2) isoflurane: 3.5±1.8 vol% (mice) and 3.9±1.2 vol% (rats); 3) ketamine/xylazine: 80.0±0.0/10.0±0.0 mg/kg (rats). Route of administration was not reported in 130/348 (37.3%) interventions using anesthesia for euthanasia. Inhalative, intraperitoneal, intravenous, subcutaneous and intracardial administration was used in 92/348 (26.4%), 113/348 (32.5%), 11/348 (3.2%), 1/348 (0.3%) and 1/348 (0.3%) interventions using anesthesia for euthanasia. In 6/501 interventions with reported euthanasia (1.2%), the method used (single urethane overdose without additional euthanasia procedure) was deemed unacceptable for euthanasia in laboratory animals according to the American Veterinary Medical Association (AVMA) guidelines for the euthanasia of animals \[[@pone.0134205.ref022]\].

![Frequencies of euthanasia.\
Values are given as numbers and percentages relative to the total number (below pie diagram). A: Type of Euthanasia, Anesthesia\*: anesthesia overdose 121 (25%), anesthesia overdose + transcardial perfusion 135 (28%), anesthesia overdose + decapitation 38 (8%), anesthesia overdose + removal of vital organs 17 (4%), anesthesia overdose + exsanguination 37 (8%), number and percentage relative to total, respectively. B: Euthanasia drugs. Inhalational: isoflurane 47 (13%), carbon dioxide 29 (8%), number and percentage relative to total, respectively. \#: urethane is not recommended as sole method for euthanasia of small laboratory mammals by the guidelines of the American Veterinary Medical Association (AVMA) guidelines for the euthanasia of animals \[[@pone.0134205.ref022]\] due to its slow onset of action. Other: drugs with \<2% occurrence. n/s: not specified.](pone.0134205.g004){#pone.0134205.g004}

### Monitoring and mechanical ventilation {#sec019}

No monitoring was described in 439/732 (60.0%) interventions involving anesthesia. Monitoring reported during anesthesia is depicted in [Fig 5](#pone.0134205.g005){ref-type="fig"}. In the remaining 293/732 (40.0%) procedures involving anesthesia, the use of monitoring techniques were described for anesthesia purposes, experimental procedure or both in 114/293 (38.9%), 26/293 (8.9%) and 113/293 (38.6%) interventions, respectively. In 40/293 interventions (13.7%), the intention of the monitoring was not specified. Venous and arterial accesses were reported in 141/845 (16.6%) and 138/845 (16.3%) of the analyzed manuscripts. Temperature was monitored in 198/732 (27.0%) interventions involving anesthesia. Detailed frequency of reporting of monitoring with respect to journal category and impact factor is shown in [Table 4](#pone.0134205.t004){ref-type="table"}.

![Frequencies of monitoring.\
Values are given as number; percentage relative to total number of interventions involving anesthesia (732/1041). ECG: electrocardiogramm, blood pressure: noninvasive or invasive, oxygenation: blood gas analysis or pulse plethysmography, cardiac pressures include ventricular or atrial pressures, pulmonary arterial pressure or central venous pressure.](pone.0134205.g005){#pone.0134205.g005}

Mechanical ventilation during anesthesia was described in 179/732 (24.5%) interventions ([Table 6](#pone.0134205.t006){ref-type="table"}). For monitoring during mechanical ventilation, the measurement of arterial blood pressure, blood gas analyses and spirometry was reported more frequently compared to interventions without mechanical ventilation (92, 51.4% *vs*. 61, 34.1%; 60, 33.5% *vs*. 24, 13.4% and 43, 24.0% *vs*. 19, 10.6%; values given as total number of interventions, percentage of interventions involving mechanical ventilation; mechanical ventilation vs. no mechanical ventilation). The mean tidal volume (mean ± standard deviation) used during mechanical ventilation was reported as 13.1±8.4 ml/kg (mice), 8.5±5.2 ml/kg (rats) and 7.1±2.1 ml/kg (rabbits). The mean respiratory rate (mean ± standard deviation) was reported as 155±68 per min for mice, 71±24 per min for rats, 80±0 for guinea pigs and 44±18 per min for rabbits. The fraction of inspired oxygen (mean ± standard deviation) during mechanical ventilation was described as 54 ± 35% (mice), 58 ± 33% (rats) and 68 ± 36 (rabbits). For guinea pigs no fraction of inspired oxygen and tidal volume settings were reported.

10.1371/journal.pone.0134205.t006

###### Frequency of reported mechanical ventilation.

![](pone.0134205.t006){#pone.0134205.t006g}

                                Airway        Settings                                                                                                                            
  --------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- --------------- ----------------- ------------- ------------- -------------
  reported        179 (24.5)    10 (5.6)      90 (50.3)     76 (42.5)     36 (20.1)     71 (39.7)     91 (50.8)     90 (50.3)       59 (33.0)         6 (3.4)       2 (1.1)       49 (27.4)
  not reported    553 (75.5)    169 (94.4)    89 (49.7)     103 (57.5)    141 (78.8)    106 (59.2)    77 (43.0)     86 (48.0)       116 (64.8)        173 (96.6)    177 (98.9)    129 (72.1)
  not specified   0 (0.0)       0 (0.0)       0 (0.0)       0 (0.0)       2 (1.1)       1 (0.6)       11 (6.1)      3 (1.7)         4 (2.2)           0 (0.0)       0 (0.0)       1 (0.6)
  total           732 (100.0)   179 (100.0)   179 (100.0)   179 (100.0)   179 (100.0)   179 (100.0)   179 (100.0)   179 (100.0)     179 (100.0)       179 (100.0)   179 (100.0)   179 (100.0)
  mean value                                                                                                        10.3±7.0ml/kg   2.8±1.8 cmH~2~O                               

Values are given as number (% relative to total). MV: mechanical ventilation, SGA: supraglottic airway including supplemental oxygen inflation via nose cone and mask, TS: tracheostomy, ETT: endotracheal intubation, F~I~O~2~: fraction of inspired oxygen, RR: respiratory rate, V~T~: tidal volume, PEEP: positive endexpiratory pressure, ETCO~2~: end tidal carbon dioxide, I:E: inspiration/expiration-ratio.

### Differences among categories and impact factor ratings {#sec020}

Significant differences among subject categories and impact factor ratings were found for many items covered in the ARRIVE guidelines, when comparing frequencies of reporting ([Table 4](#pone.0134205.t004){ref-type="table"}). Studies reporting animal characteristics were inhomogeneously distributed among the categories, with more articles with incomplete reporting especially found in lower-impact factor journals and journals from the category \'Respiratory System\'. Anesthesia was also reported inhomogeneously, with most papers reporting anesthesia published in lower-impact factor and Anesthesia journals. Inhomogeneous distribution of articles reporting euthanasia was found, too. Most articles not providing sufficient information on euthanasia were published in journals from the category \'Respiratory System\' and lower-impact factor journals. Most papers not reporting monitoring come from \'Respiratory System\' journals, while no inhomogeneous distribution between lower and higher impact factors were found.

Discussion {#sec021}
==========

Main findings {#sec022}
-------------

Of the 845 studies included in the present review, many reported anesthesia and euthanasia procedures, while failing to provide detailed information on the performed procedures and the characteristics of the treated animals.

Strengths and limitations {#sec023}
-------------------------

This review focuses on articles published in journals listed in the three Web of Knowledge subject categories closely related to anesthesia, so frequent use of anesthetic procedures throughout the interventions, high reporting rates and experience with small laboratory mammal anesthesia were postulated. The strength of this review lies in the comprehensive search strategy containing 30 journals and explicit inclusion and exclusion criteria. Trial selection and data abstraction were performed in duplicate.

The present systematic review has several limitations. First, the occurrence of under-reporting of monitoring, anesthesia and euthanasia practice could be a major source of bias when evaluating frequency and quality of reporting. This review focused on the quality of reporting within the manuscripts or additional files if available. Second, this systematic review is not completely reported according to the PRISMA guidelines \[[@pone.0134205.ref019]\], since those guidelines have been developed for clinical trials. Nevertheless, we followed these guidelines whenever possible. Third, only three categories from the 2012 Journal Citation Reports \[[@pone.0134205.ref020]\] have been investigated. Therefore, no conclusions about other categories can be drawn. Fourth, only a one-year period was analyzed and therefore no long-term conclusions can be drawn about developments of anesthesiological practice and quality of reporting. Fifth, tools for assessing bias like standards for clinical trials \[[@pone.0134205.ref023]\] are not available for experimental studies. Considering the large quantity of non-reported items revealed by this review, such tools are possibly unusable in this study. Due to the large amount of data reported incompletely, only a descriptive statistical approach was taken without performing meta-analysis. Additionally, the ARRIVE guidelines \[[@pone.0134205.ref018]\] were published in 2010 and the time for adaption of the guidelines in all manuscripts could have been too short. However, those guidelines summarize only general knowledge comparable to 'good clinical practice' for clinical trials. In our opinion, quality standards similar to clinical studies with respect to reporting and clinical practice should be established and followed in basic research employing animal models.

Quality of reporting {#sec024}
--------------------

Based on the findings of this review, the quality of reporting regarding the investigated outcomes is poor. As a direct consequence, it would be difficult to reproduce the results reported in many publications. None of the 845 analyzed papers reported on all items of the ARRIVE guidelines \[[@pone.0134205.ref018]\]. Omission of items is not a violation of the guidelines and explicitly allowed, but could make reproduction of results difficult.

Frequency of reporting {#sec025}
----------------------

Most articles failed to provide details on sample size calculation. Data on basic animal characteristics, especially the number of animals used as well as age and weight, was lacking in approximately 50% of the articles. Animal care approval was also described in only approximately 85% of the manuscripts. Unanticipated mortality due to anesthetic drugs or experimental procedures was rarely reported, introducing a significant survivor bias. The reporting of animal characteristics, anesthesia, euthanasia and monitoring tended to be worst in journals belonging to the category 'Respiratory System'. One possible explanation for this finding is that there are more manuscripts related to basic research in this category. In contrast journals with advising guidelines regarding anesthesia showed lower frequencies of reported anesthetic methods. This could be based on the fact that more manuscripts involving anesthesia were published in journals without advising guidelines. These findings are supported by a recently published study investigating the ethical quality of reporting in three journals related to critical care \[[@pone.0134205.ref017]\]. Cultural differences between basic research and both human clinical research with its strict rules concerning reporting of studies and human as well as veterinary clinical anesthesiology could contribute to this phenomenon. Despite of these potential differences, authors from basic research should strive for completeness of reporting on clinical procedures performed during studies, for example by considering the ARRIVE guidelines \[[@pone.0134205.ref018]\].

In spite of this lack of reported data, all investigated manuscripts passed a peer-review and editorial board process. Possible explanations for the lack of basic information regarding animal characteristics, animal care approval and relevant information regarding anesthesia and euthanasia are: 1) due to space constrains in the methods sections of the respective journals, the authors may not elaborate on these characteristics more extensively, especially if the opportunity of an online data supplement is not available; 2) editors and reviewers are confronted with a large amount of manuscripts, 3) the review process might be more focused on the results and their interpretation than on formal requirements of the method section.

Ways to improve quality and frequency of reporting {#sec026}
--------------------------------------------------

To improve quality and frequency of reporting, potential space constraints could be addressed by accepting online supplementary data. Furthermore, journals could include a checkbox with a statement of institutional animal care and use committee approval in the journal submission mask, as well as a checkbox to indicate that authors have read the ARRIVE guidelines \[[@pone.0134205.ref018]\]. During peer review, the ARRIVE guidelines \[[@pone.0134205.ref018]\] could be considered to ensure that all information is provided in the manuscript to adequately characterize a given animal study. However, it cannot be in the journals' responsibility, but rather the respective institutional animal care and use committees', to make sure that the reported study has been performed in accordance with the approved animal protocols.

Pain management {#sec027}
---------------

Detecting states of pain in small laboratory mammals requires careful behavioral assessment \[[@pone.0134205.ref024],[@pone.0134205.ref025]\] and can be challenging \[[@pone.0134205.ref026]--[@pone.0134205.ref029]\]. Researchers and animal care personnel have to be trained to recognize painful animal behavior to prevent unnecessary suffering \[[@pone.0134205.ref030]\].

For possibly painful interventions, administration of analgesic drugs during maintenance of anesthesia in addition to sedative agents is frequently used in humans \[[@pone.0134205.ref031]\]. In the animal studies included in this review, the administration of analgesics was reported in only 19.1% of all painful interventions describing drugs for anesthesia maintenance. However, this fact should be interpreted with caution because of bias due to possible underreporting as previously mentioned. Insufficient analgesia can cause hemodynamic instability and stress responses on metabolic and hormone level, which may influence the experimental endpoints \[[@pone.0134205.ref032]\]. On the other hand, analgesic substances can influence animal outcomes by modulation of inflammatory pathways (non-steroidal anti-inflammatory drugs) or impair respiratory drive, requiring mechanical ventilation (opioid analgesics). As a direct consequence the specific research question and choice of sedative and/or analgesic drugs have to be balanced individually. The role of the institutional animal care and use committee is therefore crucial to evaluate the importance of the scientific needs in the context of animal welfare.

The extension of analgesic therapy into the post-operative period after painful interventions is a key element to modern human anesthetic strategies and a hallmark of humane animal care in laboratory research \[[@pone.0134205.ref033]\]. In animal research, post-operative pain management is important in order to minimize animal suffering and reduce post-operative stress \[[@pone.0134205.ref012]\]. In the present review, only in 10.4% of the interventions in which animals initially survived the respective procedure, post-operative treatment with analgesic agents was reported. In context of the published literature, intra- and post-operative analgesic therapy is rarely performed \[[@pone.0134205.ref007],[@pone.0134205.ref014],[@pone.0134205.ref017]\]. Therefore, some of the investigated journals (e.g. British Journal of Anaesthesia, Anesthesiology, Journals of the American Thoracic Society and the American Journal of Physiology- Lung Cellular and Molecular Physiology) advise researchers in their instructions for authors regarding anesthesia in laboratory animals \[[@pone.0134205.ref034]--[@pone.0134205.ref037]\]. The British Journal of Anaesthesia highlighted that e.g. a single intraperitoneal pentobarbital anesthesia alone is insufficient to provide analgesia. Nevertheless this strategy was frequently found in the present review. Also the use of postoperative pain therapy was recommended, whenever necessary \[[@pone.0134205.ref034]\].

General considerations {#sec028}
----------------------

Some principles of anesthesia may seem unintuitive for researchers without explicit anesthesiological background. In addition, anesthesia in small laboratory mammals varies in part from clinical practice. The main risks of anesthesia in small laboratory animals are hypotension, hypoxemia, hypoventilation and hypothermia, which need to be considered in planning and performing the experiments.

First, preanesthetic medication (sedation and analgesia), especially prior to painful interventions. reduces apprehension and stress resulting in lower intraoperative doses of anesthetic agents and reduction of side effects such as hypotension \[[@pone.0134205.ref038]\]. In contrast, in the present review, only few studies reported the use of sedative premedication, and only 19% of these trials described additional use of analgesics. Increased animal stress levels, resulting from a lack of premedication, may modulate inflammatory response and compromise experimental results \[[@pone.0134205.ref039]\].

Second, management of body temperature is essential since small laboratory mammals are at high risk for intraoperative hypothermia due to their high relative body surface compared to body weight. Physiological functions as immunological response and hemostasis are highly temperature-dependent \[[@pone.0134205.ref040],[@pone.0134205.ref041]\]. Therefore, close temperature monitoring and management is crucial for experiments to be comparable and reproducible. Only in 20% of the anesthetic procedures body temperature monitoring was described.

Third, hemodynamic monitoring is an important tool for titrating depth of anesthesia and avoiding cardiovascular depression especially if the animal is paralyzed \[[@pone.0134205.ref042]\]. In order to obtain accurate and reproducible measurements, it is important to use devices specifically designed for monitoring and mechanical ventilation of small laboratory mammals. Specific methods based on neuro-monitoring to determine depth of anesthesia available in humans are unusable in small laboratory mammals due to technical limitations \[[@pone.0134205.ref043]\]. Apart from the reaction to a painful stimulus, hemodynamic monitoring is another method for assessing sufficient anesthesia \[[@pone.0134205.ref044]\]. In approximately 40% of the anesthetic procedures hemodynamic monitoring was reported.

Fourth, the sex of the animal can have an effect on the anesthetic dosage, due to differences in metabolism and lean body mass \[[@pone.0134205.ref045]\]. Furthermore, anesthetic dosage is also influenced by the age of the small laboratory mammal, which means that younger animals need higher doses than older animals in relation to their body weight \[[@pone.0134205.ref046]--[@pone.0134205.ref048]\].

Fifth, routine fluid therapy for hemodynamic stabilization was only described in few interventions, most commonly using saline. In contrast, balanced crystalloid solution has become standard of care in human clinical practice \[[@pone.0134205.ref049]\].

Sixth, the method of euthanasia should be performed according to the AVMA guidelines \[[@pone.0134205.ref022]\]. In the present systematic review, in six manuscripts single urethane injections for euthanasia were used, mainly with approval of an institutional animal care and use committee. Alternative euthanasia methods could have been used in the opinion of the authors. Researchers as well as members of the institutional animal care and use committees should be aware of the ethical guidelines regarding euthanasia while conducting and reviewing animal experiments.

Implication for further studies {#sec029}
-------------------------------

As for all types of medications, effects as well as side effects of anesthesia need to be considered carefully. For many anesthetic agents, common side effects as cardiorespiratory depression in rodent models are described \[[@pone.0134205.ref006]\]. Apart from that, there is strong evidence that anesthetic and analgesic drugs have immunomodulatory properties \[[@pone.0134205.ref050]--[@pone.0134205.ref052]\], which have the potential to influence outcomes in many experimental settings, e.g. joint inflammation and sepsis. Similar effects are known for carbon dioxide which was used for euthanasia in some interventions \[[@pone.0134205.ref053]\]. Concerns about distress and pain with carbon dioxide euthanasia are also raised \[[@pone.0134205.ref054]\]. However, AVMA guidelines \[[@pone.0134205.ref022]\] state that euthanasia with carbon dioxide is "acceptable with conditions" for laboratory rodents and other species. It is important to consider the effects of anesthesia and euthanasia in the context of the respective study protocols.

Reproducibility is an essential criterion for the validity of experimental research. The problem of insufficient reporting of data contributes to a lack of reproducibility, as seen in recent publications on cancer research \[[@pone.0134205.ref055],[@pone.0134205.ref056]\]. The incomplete data provided in some manuscripts would make it difficult to reproduce the respective findings and compare them to other experiments.

Whenever study protocols allow, we believe that anesthesia management in small laboratory mammals for laboratory research should include premedication, hypnotic and analgesic agents as well as postoperative pain therapy. Basic monitoring of anesthesia should include at least heart rate and body temperature. Side effects of anesthetic agents should be considered while designing the research protocol and unexpected mortality of laboratory animals should be reported in the publication.

In the context of this review, guidelines for small laboratory mammals anesthesia based on more than expert consensus are desirable as already established for other species \[[@pone.0134205.ref057],[@pone.0134205.ref058]\]. Ideally, these guidelines should be embraced by the leading societies in human and veterinary medicine. Concerning quality of reporting, both authors and reviewers should strive towards provision of all basic study information, for example by considering the ARRIVE guidelines \[[@pone.0134205.ref018]\].

Conclusion {#sec030}
==========

The present systematic review revealed insufficient reporting of anesthesia and euthanasia methods throughout experimental studies in small laboratory mammals. Furthermore, the present review shows that there is a high need for application of existing guidelines for reporting experimental animal research. Specific guidelines for anesthesia and euthanasia regimens should be considered and reported in future studies to guarantee comparability as well as quality of animal experiments. This is of special interest when translating experimental findings to future clinical applications.
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